Product correctly added to cart.

discount label
PF-06869206
View 3D

Biosynth logo

PF-06869206

CAS: 2227425-05-8

Ref. 3D-CPD42505

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Wednesday 12 Feb 2025

Product Information

Name:
PF-06869206
Description:

PF-06869206 is a binder that binds to the parathyroid hormone receptor and inhibits its activity. It is used for the treatment of chronic kidney disease, where it reduces urinary flow rate and inhibits growth factor production, thereby reducing bone loss. PF-06869206 has been shown to lower blood calcium levels in wild-type mice with high-calcium diets, but does not affect the calcium levels of wild-type mice with low-calcium diets. This drug also inhibits parathyroid hormone secretion and decreases renal excretion of phosphate and chloride in vivo studies.
PF-06869206 is orally bioavailable and can be given both once or twice daily. In vivo studies have shown that this drug has nonselective binding properties as it binds to both active and inactive forms of the parathyroid hormone receptor.br>

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
374.75 g/mol
Formula:
C15H14ClF3N4O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-CPD42505 PF-06869206

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".